{
    "id": 58,
    "premise": "none",
    "hypothesis": "BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans.",
    "label": "entailment",
    "explanation": "BRCA2 and RAD51 homolog 1 are both involved in HRR in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules.",
    "results": {
        "semantic validity": false,
        "premise": null,
        "hypothesis": "BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans.",
        "history explanation": [
            "0 iteration: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules.",
            "1 iteration: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules.",
            "2 iteration: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules.",
            "3 iteration: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules.",
            "4 iteration: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules.",
            "5 iteration: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules.",
            "6 iteration: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules.",
            "7 iteration: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules.",
            "8 iteration: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules.",
            "9 iteration: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules.",
            "10 iteration: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans.\nThe binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules."
        ],
        "history semantic validity": [
            "0 iteration: False",
            "1 iteration: False",
            "2 iteration: False",
            "3 iteration: False",
            "4 iteration: False",
            "5 iteration: False",
            "6 iteration: False",
            "7 iteration: False",
            "8 iteration: False",
            "9 iteration: False",
            "10 iteration: False"
        ],
        "history critique output": [
            "0 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_58_0\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51Homolog1 :: \"entity \u21d2 bool\"\\n  Humans :: \"entity \u21d2 bool\"\\n  InvolvedInHRR :: \"entity \u21d2 event \u21d2 bool\"\\n  Binding :: \"entity \u21d2 bool\"\\n  Catalyzes :: \"entity \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Joining :: \"entity \u21d2 bool\"\\n  RepairMolecules :: \"entity \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans *)\\naxiomatization where\\n  explanation_1: \"\u2200x y e. BRCA2 x \u2227 RAD51Homolog1 y \u2227 Humans e \u27f6 (InvolvedInHRR x e \u2227 InvolvedInHRR y e)\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. BRCA2 x \u2227 RAD51Homolog1 y \u2227 Binding z \u2227 Catalyzes e \u2227 Agent e z \u2227 Patient e x \u2227 Patient e y \u2227 Joining e \u2227 Patient e z\"\\n\\n\\ntheorem hypothesis:\\n  assumes asm: \"BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans *)\\n  shows \"\u2203x y z e. BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y \u2227 Joining e \u2227 Agent e x \u2227 Patient e y \u2227 Via e (RAD51Homolog1) \u2227 InHumans e\"\\nproof -\\n  (* From the premise, we have information about BRCA2, RepairMolecules, Undamaged, and Homologous. *)\\n  from asm have \"BRCA2 x\" and \"RepairMolecules y\" and \"Undamaged y\" and \"Homologous y\" <ATP>\\n  \\n  (* We know from the explanation that BRCA2 and RAD51 homolog 1 are both involved in HRR in humans. *)\\n  (* There is a logical relation Implies(A, B), Implies(BRCA2 and RAD51 homolog 1 are both involved in HRR in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules) *)\\n  (* We can infer that the binding catalyzes the joining of undamaged homologous molecules. *)\\n  obtain z e where \"Binding z\" and \"Catalyzes e\" and \"Agent e z\" and \"Patient e x\" and \"Patient e y\" and \"Joining e\" <ATP>\\n  \\n  (* We have all the necessary components to satisfy the hypothesis. *)\\n  then have \"BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y \u2227 Joining e \u2227 Agent e x \u2227 Patient e y \u2227 Via e (RAD51Homolog1) \u2227 InHumans e\" <ATP>\\n  \\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans (from Explanatory Sentence 1)\\nB: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(BRCA2 and RAD51 homolog 1 are both involved in HRR in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\n\\nDerived Implications:\\n'}",
            "1 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_58_1\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51Homolog1 :: \"entity \u21d2 bool\"\\n  Humans :: \"entity \u21d2 bool\"\\n  InvolvedInHRR :: \"entity \u21d2 event \u21d2 bool\"\\n  Binding :: \"entity \u21d2 bool\"\\n  Catalyzes :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Joining :: \"entity \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n  RepairMolecules :: \"entity \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans *)\\naxiomatization where\\n  explanation_1: \"\u2200x y e. BRCA2 x \u2227 RAD51Homolog1 y \u2227 Humans e \u27f6 (InvolvedInHRR x e \u2227 InvolvedInHRR y e)\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. BRCA2 x \u2227 RAD51Homolog1 y \u2227 Binding z \u2227 Catalyzes e \u2227 Agent e z \u2227 Patient e x \u2227 Patient e y \u2227 Joining z \u2227 Undamaged y \u2227 Homologous y\"\\n\\n\\ntheorem hypothesis:\\n  assumes asm: \"BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans *)\\n  shows \"\u2203x y z e. BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y \u2227 Joining e \u2227 Agent e x \u2227 Patient e y \u2227 Via e (RAD51Homolog1) \u2227 InHumans e\"\\nproof -\\n  (* From the premise, we have information about BRCA2, RepairMolecules, Undamaged, and Homologous. *)\\n  from asm have \"BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y\" <ATP>\\n  (* We know from the explanation that BRCA2 and RAD51 homolog 1 are both involved in HRR in humans. *)\\n  (* This corresponds to the logical proposition A. *)\\n  (* Since BRCA2 is involved in HRR, it is related to the binding and catalyzing of molecules. *)\\n  (* There is a logical relation Implies(A, B), Implies(BRCA2 and RAD51 homolog 1 are both involved in HRR in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules) *)\\n  (* We can infer the joining of molecules from the premise and explanation. *)\\n  then obtain z e where \"Joining z \u2227 Agent e z \u2227 Patient e x \u2227 Patient e y \u2227 Via e (RAD51Homolog1) \u2227 InHumans e\" <ATP>\\n  (* Combining all the necessary information, we can conclude the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans (from Explanatory Sentence 1)\\nB: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(BRCA2 and RAD51 homolog 1 are both involved in HRR in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\n\\nDerived Implications:\\n'}",
            "2 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_58_2\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51Homolog1 :: \"entity \u21d2 bool\"\\n  Humans :: \"entity \u21d2 bool\"\\n  InvolvedInHRR :: \"entity \u21d2 event \u21d2 bool\"\\n  Binding :: \"entity \u21d2 bool\"\\n  Catalyzes :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Joining :: \"entity \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n  RepairMolecules :: \"entity \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans *)\\naxiomatization where\\n  explanation_1: \"\u2200x y e. BRCA2 x \u2227 RAD51Homolog1 y \u2227 Humans e \u27f6 (InvolvedInHRR x e \u2227 InvolvedInHRR y e)\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. BRCA2 x \u2227 RAD51Homolog1 y \u2227 Binding z \u2227 Catalyzes e \u2227 Agent e z \u2227 Patient e x \u2227 Patient e y \u2227 Joining z \u2227 Undamaged y \u2227 Homologous y\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Humans e\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans *)\\n  shows \"\u2203x y z e. BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y \u2227 Joining e \u2227 Agent e x \u2227 Patient e y \u2227 Via e (RAD51Homolog1) \u2227 InHumans e\"\\nproof -\\n  (* From the premise, we know that humans are involved. *)\\n  from asm have \"Humans e\" <ATP>\\n  (* We have the logical proposition A from explanatory sentence 1. *)\\n  (* There is a logical relation Implies(A, B), Implies(BRCA2 and RAD51 homolog 1 are involved in HRR in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules) *)\\n  (* Both A and B are from explanatory sentences 1 and 2. *)\\n  (* We can infer the hypothesis from B. *)\\n  then have \"\u2203x y z e. BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y \u2227 Joining e \u2227 Agent e x \u2227 Patient e y \u2227 Via e (RAD51Homolog1) \u2227 InHumans e\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 and RAD51 homolog 1 are involved in HRR in humans (from Explanatory Sentence 1)\\nB: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(BRCA2 and RAD51 homolog 1 are involved in HRR in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\n\\nDerived Implications:\\n'}",
            "3 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_58_3\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51Homolog1 :: \"entity \u21d2 bool\"\\n  Humans :: \"entity \u21d2 bool\"\\n  InvolvedInHRR :: \"entity \u21d2 event \u21d2 bool\"\\n  Binding :: \"entity \u21d2 bool\"\\n  Catalyzes :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Joining :: \"event \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n  Molecules :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans *)\\naxiomatization where\\n  explanation_1: \"\u2200x y e. BRCA2 x \u2227 RAD51Homolog1 y \u2227 Humans e \u27f6 (InvolvedInHRR x e \u2227 InvolvedInHRR y e)\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. BRCA2 x \u2227 RAD51Homolog1 y \u2227 Binding z \u2227 Catalyzes e \u2227 Agent e z \u2227 Patient e x \u2227 Patient e y \u2227 Joining e \u2227 Undamaged x \u2227 Homologous x \u2227 Molecules x\"\\n\\n\\ntheorem hypothesis:\\n  assumes asm: \"BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans *)\\n  shows \"\u2203x y z e. BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y \u2227 Joining e \u2227 Agent e x \u2227 Patient e y \u2227 Via e \\'\\'RAD51 homolog 1\\'\\' \u2227 InHumans e\"\\nproof -\\n  (* From the premise, we have information about BRCA2, repair molecules, undamaged, and homologous molecules. *)\\n  from asm have \"BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y\" <ATP>\\n  (* We know from the explanation that BRCA2 and RAD51 homolog 1 are both involved in HRR in humans. *)\\n  (* There is a logical relation Implies(A, B), Implies(BRCA2 and RAD51 homolog 1 are both involved in HRR in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules) *)\\n  (* We can infer that the binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)\\n  then have \"Joining e \u2227 Agent e x \u2227 Patient e y \u2227 Via e \\'\\'RAD51 homolog 1\\'\\' \u2227 InHumans e\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans (from Explanatory Sentence 1)\\nB: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(BRCA2 and RAD51 homolog 1 are both involved in HRR in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\n\\nDerived Implications:\\n'}",
            "4 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_58_4\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51Homolog1 :: \"entity \u21d2 bool\"\\n  Humans :: \"entity \u21d2 bool\"\\n  InvolvedInHRR :: \"entity \u21d2 entity \u21d2 bool\"\\n  Binding :: \"entity \u21d2 bool\"\\n  Catalyzes :: \"entity \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Joining :: \"event \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n  RepairMolecules :: \"entity \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans *)\\naxiomatization where\\n  explanation_1: \"\u2200x y z. BRCA2 x \u2227 RAD51Homolog1 y \u2227 Humans z \u27f6 (InvolvedInHRR x z \u2227 InvolvedInHRR y z)\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. BRCA2 x \u2227 RAD51Homolog1 y \u2227 Binding z \u2227 Catalyzes e \u2227 Agent e z \u2227 Patient e x \u2227 Patient e y \u2227 Joining e \u2227 Undamaged x \u2227 Homologous x\"\\n\\ntheorem hypothesis:\\n assumes asm: \"BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans *)\\n shows \"\u2203x y z e. BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y \u2227 Joining e \u2227 Agent e x \u2227 Patient e y \u2227 Via e z \u2227 RAD51Homolog1 z \u2227 Humans z\"\\nproof -\\n  (* From the premise, we have information about BRCA2, RepairMolecules, Undamaged, and Homologous. *)\\n  from asm have \"BRCA2 x\" and \"RepairMolecules y\" and \"Undamaged y\" and \"Homologous y\" <ATP>\\n  \\n  (* We know from the explanation that BRCA2 and RAD51 homolog 1 are involved in HRR in humans. *)\\n  (* There is a logical relation Implies(A, B), Implies(BRCA2 and RAD51 homolog 1 are involved in HRR in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules) *)\\n  (* We can infer the binding, catalyzes, joining, agent, patient, via, and humans from the explanation. *)\\n  obtain a b c d where \"Binding a\" and \"Catalyzes b\" and \"Joining d\" and \"Agent b c\" and \"Patient b x\" and \"Patient b y\" and \"Via b c\" and \"RAD51Homolog1 c\" and \"Humans c\" \\n    <ATP>\\n  \\n  (* Combining the information from the premise and the derived information, we can derive the hypothesis. *)\\n  have \"BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y \u2227 Joining d \u2227 Agent b x \u2227 Patient b y \u2227 Via b c \u2227 RAD51Homolog1 c \u2227 Humans c\" \\n    <ATP>\\n  \\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 and RAD51 homolog 1 are involved in HRR in humans (from Explanatory Sentence 1)\\nB: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(BRCA2 and RAD51 homolog 1 are involved in HRR in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\n\\nDerived Implications:\\n'}",
            "5 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_58_5\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51Homolog1 :: \"entity \u21d2 bool\"\\n  Humans :: \"entity \u21d2 bool\"\\n  InvolvedInHRR :: \"entity \u21d2 event \u21d2 bool\"\\n  Binding :: \"entity \u21d2 bool\"\\n  Catalyzes :: \"entity \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Joining :: \"event \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans *)\\naxiomatization where\\n  explanation_1: \"\u2200x y e. BRCA2 x \u2227 RAD51Homolog1 y \u2227 Humans e \u27f6 (InvolvedInHRR x e \u2227 InvolvedInHRR y e)\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. BRCA2 x \u2227 RAD51Homolog1 y \u2227 Binding z \u2227 Catalyzes e \u2227 Agent e z \u2227 Patient e x \u2227 Patient e y \u2227 Joining e \u2227 Undamaged y \u2227 Homologous y\"\\n\\n\\ntheorem hypothesis:\\n  assumes asm: \"BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans *)\\n  shows \"\u2203x y z e. BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y \u2227 Joining e \u2227 Agent e x \u2227 Patient e y \u2227 Via e \\'\\'RAD51 homolog 1\\'\\' \u2227 InHumans e\"\\nproof -\\n  (* From the premise, we have information about BRCA2, RepairMolecules, Undamaged, and Homologous. *)\\n  from asm have \"BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y\" <ATP>\\n  (* We know from the explanation that BRCA2 and RAD51 homolog 1 are both involved in HRR in humans. *)\\n  (* There is a logical relation Implies(A, B), Implies(BRCA2 and RAD51 homolog 1 are both involved in HRR in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules) *)\\n  (* We can infer that the binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)\\n  then obtain z e where \"Binding z \u2227 Catalyzes e \u2227 Agent e z \u2227 Patient e x \u2227 Patient e y \u2227 Joining e \u2227 Undamaged y \u2227 Homologous y\" <ATP>\\n  (* We have all the necessary components to prove the hypothesis. *)\\n  then have \"BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y \u2227 Joining e \u2227 Agent e x \u2227 Patient e y \u2227 Via e \\'\\'RAD51 homolog 1\\'\\' \u2227 InHumans e\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans (from Explanatory Sentence 1)\\nB: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(BRCA2 and RAD51 homolog 1 are both involved in HRR in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\n\\nDerived Implications:\\n'}",
            "6 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_58_6\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51Homolog1 :: \"entity \u21d2 bool\"\\n  Humans :: \"entity \u21d2 bool\"\\n  InvolvedInHRR :: \"entity \u21d2 event \u21d2 bool\"\\n  Binding :: \"entity \u21d2 bool\"\\n  Catalyzes :: \"entity \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Joining :: \"event \u21d2 bool\"\\n  RepairMolecules :: \"entity \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans *)\\naxiomatization where\\n  explanation_1: \"\u2200x y e. BRCA2 x \u2227 RAD51Homolog1 y \u2227 Humans e \u27f6 (InvolvedInHRR x e \u2227 InvolvedInHRR y e)\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. BRCA2 x \u2227 RAD51Homolog1 y \u2227 Binding z \u2227 Catalyzes e \u2227 Agent e z \u2227 Patient e x \u2227 Patient e y \u2227 Joining e \u2227 Patient e z\"\\n\\n\\ntheorem hypothesis:\\n  assumes asm: \"BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans *)\\n  shows \"\u2203x y z e. BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y \u2227 Joining e \u2227 Agent e x \u2227 Patient e y \u2227 Via e (RAD51Homolog1) \u2227 InHumans e\"\\nproof -\\n  (* From the premise, we know that BRCA2 is related to repair molecules, undamaged molecules, and homologous molecules. *)\\n  from asm have \"BRCA2 x\" and \"RepairMolecules y\" and \"Undamaged y\" and \"Homologous y\" <ATP>\\n  \\n  (* We have the logical proposition A: BRCA2 and RAD51 homolog 1 are involved in HRR in humans. *)\\n  (* There is a logical relation Implies(A, B), which states that if BRCA2 and RAD51 homolog 1 are involved in HRR in humans, then the binding of them catalyzes the joining of undamaged homologous molecules. *)\\n  (* We can use this relation to infer the joining of undamaged homologous molecules. *)\\n  from explanation_1 and asm have \"InvolvedInHRR x e\" and \"InvolvedInHRR (RAD51Homolog1) e\" <ATP>\\n  from explanation_2 and `InvolvedInHRR x e` and `InvolvedInHRR (RAD51Homolog1) e` obtain \"Joining e\" <ATP>\\n  \\n  (* We also know that BRCA2 is the agent and repair molecules are the patient in the event. *)\\n  from asm have \"Agent e x\" and \"Patient e y\" <ATP>\\n  \\n  (* Additionally, we can infer that the event is in humans. *)\\n  from explanation_1 and asm have \"Humans e\" <ATP>\\n  \\n  (* Finally, we can conclude the hypothesis by combining all the inferred information. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 and RAD51 homolog 1 are involved in HRR in humans (from Explanatory Sentence 1)\\nB: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(BRCA2 and RAD51 homolog 1 are involved in HRR in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\n\\nDerived Implications:\\n'}",
            "7 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_58_7\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51Homolog1 :: \"entity \u21d2 bool\"\\n  Humans :: \"entity \u21d2 bool\"\\n  InvolvedInHRR :: \"entity \u21d2 event \u21d2 bool\"\\n  Binding :: \"entity \u21d2 bool\"\\n  Catalyzes :: \"entity \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Joining :: \"event \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n  RepairMolecules :: \"entity \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans *)\\naxiomatization where\\n  explanation_1: \"\u2200x y e. BRCA2 x \u2227 RAD51Homolog1 y \u2227 Humans e \u27f6 (InvolvedInHRR x e \u2227 InvolvedInHRR y e)\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. BRCA2 x \u2227 RAD51Homolog1 y \u2227 Binding z \u2227 Catalyzes e \u2227 Agent e z \u2227 Patient e x \u2227 Patient e y \u2227 Joining e \u2227 Undamaged y \u2227 Homologous y\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans *)\\n  shows \"\u2203x y z e. BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y \u2227 Joining e \u2227 Agent e x \u2227 Patient e y \u2227 Via e (RAD51Homolog1)\"\\nproof -\\n  (* From the premise, we have information about BRCA2, RepairMolecules, Undamaged, and Homologous. *)\\n  from asm have \"BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y\" <ATP>\\n  (* We know from the explanation that BRCA2 and RAD51 homolog 1 are both involved in HRR in humans. *)\\n  (* There is a logical relation Implies(A, B), Implies(BRCA2 and RAD51 homolog 1 are both involved in HRR in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules) *)\\n  (* We can infer that the binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)\\n  then obtain z e where \"Binding z \u2227 Catalyzes e \u2227 Agent e z \u2227 Patient e x \u2227 Patient e y \u2227 Joining e \u2227 Undamaged y \u2227 Homologous y\" <ATP>\\n  (* We have all the necessary components to prove the hypothesis. *)\\n  then have \"BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y \u2227 Joining e \u2227 Agent e x \u2227 Patient e y \u2227 Via e (RAD51Homolog1)\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans (from Explanatory Sentence 1)\\nB: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(BRCA2 and RAD51 homolog 1 are both involved in HRR in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\n\\nDerived Implications:\\n'}",
            "8 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_58_8\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51Homolog1 :: \"entity \u21d2 bool\"\\n  Humans :: \"entity \u21d2 bool\"\\n  InvolvedInHRR :: \"entity \u21d2 event \u21d2 bool\"\\n  Binding :: \"entity \u21d2 bool\"\\n  Catalyzes :: \"entity \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Joining :: \"entity \u21d2 bool\"\\n  RepairMolecules :: \"entity \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans *)\\naxiomatization where\\n  explanation_1: \"\u2200x y e. BRCA2 x \u2227 RAD51Homolog1 y \u2227 Humans e \u27f6 (InvolvedInHRR x e \u2227 InvolvedInHRR y e)\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. BRCA2 x \u2227 RAD51Homolog1 y \u2227 Binding z \u2227 Catalyzes e \u2227 Agent e z \u2227 Patient e x \u2227 Patient e y \u2227 Joining z\"\\n\\n\\ntheorem hypothesis:\\n  assumes asm: \"BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans *)\\n  shows \"\u2203x y z e. BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y \u2227 Joining e \u2227 Agent e x \u2227 Patient e y \u2227 Via e (RAD51Homolog1)\"\\nproof -\\n  (* From the premise, we have information about BRCA2, RepairMolecules, Undamaged, and Homologous. *)\\n  from asm have \"BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y\" <ATP>\\n  (* We know from the explanation that BRCA2 and RAD51 homolog 1 are both involved in HRR in humans. *)\\n  (* There is a logical relation Implies(A, B), Implies(BRCA2 and RAD51 homolog 1 are both involved in HRR in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules) *)\\n  (* We can infer that the binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)\\n  then obtain z e where \"Binding z \u2227 Catalyzes e \u2227 Agent e z \u2227 Patient e x \u2227 Patient e y \u2227 Joining z\" <ATP>\\n  (* We have obtained the necessary information to prove the hypothesis. *)\\n  then show ?thesis by <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans (from Explanatory Sentence 1)\\nB: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(BRCA2 and RAD51 homolog 1 are both involved in HRR in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\n\\nDerived Implications:\\n'}",
            "9 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_58_9\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51Homolog1 :: \"entity \u21d2 bool\"\\n  Humans :: \"entity \u21d2 bool\"\\n  InvolvedInHRR :: \"entity \u21d2 event \u21d2 bool\"\\n  Binding :: \"entity \u21d2 bool\"\\n  Molecules :: \"entity \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n  Catalyzes :: \"entity \u21d2 event \u21d2 bool\"\\n  Agent :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans *)\\naxiomatization where\\n  explanation_1: \"\u2200x y e. BRCA2 x \u2227 RAD51Homolog1 y \u2227 Humans e \u27f6 (InvolvedInHRR x e \u2227 InvolvedInHRR y e)\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. Binding x \u2227 BRCA2 y \u2227 RAD51Homolog1 z \u2227 Molecules e \u2227 Undamaged e \u2227 Homologous e \u2227 Catalyzes y e \u2227 Agent y x \u2227 Agent y z\"\\n\\n\\ntheorem hypothesis:\\n  assumes asm: \"BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans *)\\n  shows \"\u2203x y z e. BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y \u2227 Joining e \u2227 Agent e x \u2227 Patient e y \u2227 Via e \\'\\'RAD51 homolog 1\\'\\' \u2227 InHumans e\"\\nproof -\\n  (* From the premise, we have information about BRCA2, repair molecules, undamaged, and homologous molecules. *)\\n  from asm have \"BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y\" <ATP>\\n  (* We know from the explanation that BRCA2 and RAD51 homolog 1 are involved in HRR in humans. *)\\n  (* There is a logical relation Implies(A, B), Implies(BRCA2 and RAD51 homolog 1 are involved in HRR in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules) *)\\n  (* We can infer that the binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)\\n  then have \"Joining e \u2227 Agent e x \u2227 Patient e y \u2227 Via e \\'\\'RAD51 homolog 1\\'\\' \u2227 InHumans e\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 and RAD51 homolog 1 are involved in HRR in humans (from Explanatory Sentence 1)\\nB: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(BRCA2 and RAD51 homolog 1 are involved in HRR in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\n\\nDerived Implications:\\n'}",
            "10 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 12.003889560699463, 'proof tactics': ['Type unification failed: Clash of types \"_ list\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  Via e :: entity \\\\<Rightarrow> bool\\nOperand:   \\'\\'RAD51 homolog 1\\'\\' :: char list\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_58_10\\nimports Main\\n\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  BRCA2 :: \"entity \u21d2 bool\"\\n  RAD51Homolog1 :: \"entity \u21d2 bool\"\\n  Humans :: \"entity \u21d2 bool\"\\n  InvolvedInHRR :: \"entity \u21d2 bool\"\\n  Binding :: \"entity \u21d2 bool\"\\n  Joining :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  RepairMolecules :: \"entity \u21d2 bool\"\\n  Undamaged :: \"entity \u21d2 bool\"\\n  Homologous :: \"entity \u21d2 bool\"\\n  Via :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans *)\\naxiomatization where\\n  explanation_1: \"\u2200x y. BRCA2 x \u2227 RAD51Homolog1 y \u2227 Humans x \u27f6 InvolvedInHRR x \u2227 InvolvedInHRR y\"\\n\\n(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z e. Binding x \u2227 BRCA2 y \u2227 RAD51Homolog1 z \u2227 Joining e \u2227 Agent e x \u2227 Patient e y\"\\n\\ntheorem hypothesis:\\n assumes asm: \"BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y\"\\n  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans *)\\n shows \"\u2203x y z e. BRCA2 x \u2227 RepairMolecules y \u2227 Undamaged y \u2227 Homologous y \u2227 Joining e \u2227 Agent e x \u2227 Patient e y \u2227 Via e \\'\\'RAD51 homolog 1\\'\\' \u2227 InHumans e\"\\nproof -\\n  (* From the premise, we have information about BRCA2, repair molecules being undamaged and homologous. *)\\n  from asm have \"BRCA2 x\" and \"RepairMolecules y\" and \"Undamaged y\" and \"Homologous y\" <ATP>\\n  \\n  (* We know from the explanatory sentence 2 that the binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)\\n  (* There is a logical relation Implies(A, B), Implies(BRCA2 and RAD51 homolog 1 are both involved in HRR in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules) *)\\n  (* We can infer the joining event, agent, patient, and the involvement of RAD51 homolog 1 from the binding event. *)\\n  obtain a b c d where \"Binding a \u2227 BRCA2 b \u2227 RAD51Homolog1 c \u2227 Joining d \u2227 Agent d a \u2227 Patient d b\" <ATP>\\n  then have \"Joining d \u2227 Agent d a \u2227 Patient d b\" and \"Via d c\" <ATP>\\n  \\n  (* Since we have all the necessary components, we can combine them to prove the hypothesis. *)\\n  from `BRCA2 b` and `RepairMolecules y` and `Undamaged y` and `Homologous y` and `Joining d` and `Agent d a` and `Patient d b` and `Via d c` show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: BRCA2 and RAD51 homolog 1 are both involved in HRR in humans (from Explanatory Sentence 1)\\nB: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(BRCA2 and RAD51 homolog 1 are both involved in HRR in humans, The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules)\\n--------\\n\\nDerived Implications:\\n'}"
        ]
    }
}